SP126RITUXIMAB IS AN EFFECTIVE THERAPY FOR CALCINEURIN INHIBITOR RESISTANT/DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ADULTS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.